Therapeutic decision-making in oncology after surgical resection of the tumour (adjuvant treatment) is based on an assessment of the risk of tumour relapse. Risk profiling is a complex and often ...
A drug-product manufacturing classification system (MCS) for oral solid-dosage forms is proposed by an Academy of Pharmaceutical Sciences working group. A proposal for a drug-product manufacturing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results